Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method.
about
Targeted inhibition of the hepatitis C internal ribosomal entry site genomic RNA with oligonucleotide conjugatesA long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genomeUse of Aptamers as Diagnostics Tools and Antiviral Agents for Human VirusesHepatitis C virus translation inhibitors targeting the internal ribosomal entry site.Efficient HIV-1 inhibition by a 16 nt-long RNA aptamer designed by combining in vitro selection and in silico optimisation strategies.Aptamers as a novel tool for diagnostics and therapy.Netrin-1 Protects Hepatocytes Against Cell Death Through Sustained Translation During the Unfolded Protein ResponseAptamer-based therapeutics: new approaches to combat human viral diseasesUnmasking the information encoded as structural motifs of viral RNA genomes: a potential antiviral target.RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE Region.RNA aptamer-mediated interference of HCV replication by targeting the CRE-5BSL3.2 domain.Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.Improving the odds: Influence of starting pools on in vitro selection outcomes.The therapeutic potential of new investigational hepatitis C virus translation inhibitors.Activity of core-modified 10-23 DNAzymes against HCV.The functional RNA domain 5BSL3.2 within the NS5B coding sequence influences hepatitis C virus IRES-mediated translation.The chaperone-like activity of the hepatitis C virus IRES and CRE elements regulates genome dimerization.Modular evolution and increase of functional complexity in replicating RNA moleculesThe folding of the hepatitis C virus internal ribosome entry site depends on the 3'-end of the viral genome.Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery.
P2860
Q27485045-C1923CC2-CBED-4072-8B61-7BDAC003DC1DQ27489606-1A30CEFD-C6DF-4BD7-9A87-AC62247E2A2FQ28079654-CBD79630-09C7-44C9-8D22-ADA76E48B254Q34038589-5B558C6D-D086-429D-9CDB-04CB49FDD207Q34112867-961B9720-5BF8-4637-8032-53870433EDBDQ35552275-0F3334E8-EE5E-4E30-9C48-54265F78CA08Q37297058-96364842-F77E-4759-8323-2B9986487F69Q37415958-3F7CE140-62E7-419E-9B82-66F16E1F2E8CQ38132094-A12F9794-B8B4-45A3-ACD9-CB734588A53FQ38296535-DFA6B62A-A762-4970-A831-49B4E6AAF12DQ38318690-C5316794-B204-453E-AC68-329681229DBBQ38771180-73755DA5-48A5-45CB-8629-ECF288DFF3AAQ38816128-91EA27B9-B1F6-4305-87E3-26795CE8F921Q38930861-B15A721D-9CB1-4647-BADD-22D3CED22B28Q38969946-792B42D9-7A56-4E5A-9202-D324B2AF0D58Q39539402-B403D69A-5CF6-478C-A4CD-B615E9F5F3A5Q40320503-8DAA7928-6373-4B08-9CAA-712407C4BB95Q41500863-5C617412-ABCA-4C92-BFCC-A873A6F323A0Q42419693-5224E749-6460-4C09-B0C7-685266B3585FQ47104247-24256D78-9197-4F5B-A815-E2D20098E448
P2860
Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Interfering with hepatitis C v ...... vel in vitro selection method.
@en
type
label
Interfering with hepatitis C v ...... vel in vitro selection method.
@en
prefLabel
Interfering with hepatitis C v ...... vel in vitro selection method.
@en
P2093
P2860
P356
P1433
P1476
Interfering with hepatitis C v ...... ovel in vitro selection method
@en
P2093
Alicia Barroso-delJesus
Cristina Romero-López
Elena Puerta-Fernández
P2860
P304
P356
10.1515/BC.2005.023
P577
2005-02-01T00:00:00Z